Supercritical carbon dioxide utilization in drug delivery:Experimental study and modeling of paracetamol solubility
Abstract
In the present study, the solubility of paracetamol in supercritical CO2 is measured at temperatures between 311 and 358 K and pressures between 95 and 265 bar. It was shown that the solubility of paracetamol through a static solubility measurement method was between 0.3055 × 10-6 to 16.3582 × 10-6 based on mole fraction. The obtained experimental solubility data revealed the direct effect of pressure on the paracetamol experimental data, while the temperature has a dual effect of both increasing and decreasing effect considering the shifting point known as crossover pressure which was measured to be around 110 bar for paracetamol. Besides, two theoretical approaches were applied to predict the paracetamol experimental results. The experimental data were modeled with two various equations of state (EoSs) i.e. Peng-Robinson EoS and the simplified perturbed chain statistical associating fluid theory (sPC-SAFT) EoS, which their binary interaction parameters were optimized by using genetic algorithm. The obtained results demonstrated the sPC-SAFT EoS predicted the solubility of paracetamol with more accuracy (the average percent deviation was equal to 2.5215), especially at higher pressures. Furthermore, four well-known semi-empirical density-based correlations namely Mendez-Santiago and Teja (MST), Kumar-Johnston (KJ), Bartle et al., and Garlapati and Madras models were applied for modeling the solubility of paracetamol experimental data. According to self-consistency test, KJ…
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.